Measurement of Gastrointestinal (GI) and Health-related Quality of Life (HRQL) Outcomes in Liver Transplant Recipients

NCT00405652 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Liver Transplantation

Interventions

DRUG: Enteric-coated Mycophenolate sodium (EC-MPS)

Sponsor

Novartis Pharmaceuticals